Edwards Lifesciences Revenue

EW -- USA Stock  

USD 145.95  0.34  0.23%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Revenue Analysis

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Edwards Lifesciences 
Revenue 
 = 
Money Received 
Discounts and Returns 
 = 
3.55 B

Revenue Over Time Pattern

 Edwards Lifesciences Revenues 
      Timeline 

About Revenue

Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare to competition

Edwards Lifesciences Revenue Assessment

Revenue

Edwards Lifesciences Revenue Changes

Cost of Revenue

Revenues

Revenues USD

Based on latest financial disclosure Edwards Lifesciences Corporation reported 3.55 B of revenue. This is 45.38% lower than that of the Healthcare sector, and significantly higher than that of Medical Devices industry, The Revenue for all stocks is 63.95% higher than the company.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Insider Screener


 
Search macroaxis.com